Longevity Metrics AI/ML Development Study

Condition(s) studied

Investigational drug(s) / intervention(s)

AIML scored health screening battery: Video and audio-captured physical, cognitive, and observational screening tests scored by frozen, versioned AI models; models automatically score standard tests (sit-to-rise, timed walk, chair stand), predict non-performed results from performed ones, and predict clinical judgment; all outputs are physician-reviewed clinical decision aids, and no model output reaches a participant report without provider confirmation.

Study summary

This study builds AI models that score diagnostic screening tests, and that predict screening results, clinical judgment, and life expectancy. Longevity Metrics collects a battery of clinical tests on each participant, in whole or in part, and follows every participant for life.

The sit-to-rise test and the timed walk are scored by hand today, from a person's count. A model scores the same test from video instead. It also measures what no one can count by eye - speed, asymmetry, steadiness - so one capture yields both the original score and additional measurements, intended to enrich the model and strengthen what it predicts.

Every test in a participant's record measures the same body, so the tests are correlated: a test that was performed carries information about one that was not. A model trained across the library learns those relationships and estimates a missing result from the results that are present. Each estimate is checked against records where that part was actually measured, and over decades against death and disease through linkage to the 100-Year Human Aging Study (NCT07563777).

The hypothesis is that the full battery can eventually be predicted across modalities with high accuracy using a few short video clips, replacing most in-person screening. That would let preventive screening reach people and places a physical laboratory cannot. How far the input can be reduced is the question this study exists to answer.

Every model is a physician-reviewed clinical decision aid until it is cleared by the FDA.

Eligibility

Primary outcome measure(s)

• Measurement Accuracy, Non-Inferiority to Human Scoring. — At each model freeze, through study completion, up to 100 years.
  Agreement between the model's value and the reference standard, established as non-inferiority to a qualified human scorer where a human reference exists. Gates deployment as a clinical decision aid.
• Cross-Prediction of Non-Performed Results and Derived Scores — At each model freeze, through study completion, up to 100 years.
  Accuracy of predicting, from video or from the performed part of a record, both the screening results the participant did not obtain, against the measured value; and the derived scores computed from a complete record, including the Longevity Score, biological age, and estimated age at death, against the value the scoring engine produces from the full measured record.
• Prediction of Remaining Life Expectancy — Through study completion, up to 100 years
  Accuracy of predicting remaining life expectancy from video and library data, against observed mortality through linkage to the 100-Year Human Aging Study.
• Prediction of Physician Clinical Judgment — At each model freeze, through study completion, up to 100 years
  Accuracy of predicting the physician's clinical judgment where no determining measurement exists, against the sealed record. Applies to models that predict a clinical determination rather than a measured value. Where a determining test exists but was not performed, the outcome falls under Primary Outcome 2.
• Screening-Related Injuries and Adverse Events — Continuously from first screening through study completion, up to 100 years
  Participant injuries or adverse events attributed to measurements added under this study, such as the sit-to-rise test. Ascertained from two independent sources so that an event missed by one is still captured: the tester logs any fall or injury at the time of screening, and the participant reports separately on the post-screening form.

Trial sites (1)

More Longevity Metrics, Inc. trials in the USA

Other trials for the same condition